CORC  > 湖南大学
Plant-derived RNAi therapeutics: A strategic inhibitor of HBsAg
Shuo Zhang; Xiaolin Sang; Dongxia Hou; Jinmei Chen; Hongwei Gu; Yujing Zhang; Jing Li; Darong Yang; Haizhen Zhu; Xiao Yang
刊名Biomaterials
2019
关键词RNAi CHB HBsAg Artificial miRNA
ISSN号0142-9612
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4618336
专题湖南大学
作者单位1.b Department of Molecular Medicine of College of Biology, State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University, Changsha, China Research Center of Cancer Prevention and Treatment, Translational Medicine Research Center of Liver Cancer, Hunan Provincial Tumor Hospital , Changsha, 410022, China a State Key Laboratory of Pharmaceutical Biotechnology, NJU Advanced Institute for Life Sciences , School of Life Sciences, Nanjing University, 163 Xianlin Road, Nanjing, Jiangsu, 210046, China
2.Department of Gastroenterology and Hepatology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210002, China
3.State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences , Beijing Institute of Lifeomics, Beijing, 102206, China
4.Department of Clinical Laboratory, Jinling Hospital, School of Life Sciences, Nanjing University, Nanjing, 210002, China
推荐引用方式
GB/T 7714
Shuo Zhang,Xiaolin Sang,Dongxia Hou,et al. Plant-derived RNAi therapeutics: A strategic inhibitor of HBsAg[J]. Biomaterials,2019.
APA Shuo Zhang.,Xiaolin Sang.,Dongxia Hou.,Jinmei Chen.,Hongwei Gu.,...&Zhi Hong.(2019).Plant-derived RNAi therapeutics: A strategic inhibitor of HBsAg.Biomaterials.
MLA Shuo Zhang,et al."Plant-derived RNAi therapeutics: A strategic inhibitor of HBsAg".Biomaterials (2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace